Mazumdar Claire's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Mar 20, 2026
- Accession no.
- 0001628280-26-020236
- Filed
- Mar 20, 2026
- Trade date
- Mar 18-20, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $282.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazumdar ClaireCIK 0002034671 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Common Stock | MOption exerciseAcquired | +6,499 | $3.79 | +$24,631.21 | 345,891 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −6,499 | $18.84 | −$122,441.16 | 339,392 | Direct | |
| Mar 19, 2026 | Common Stock | MOption exerciseAcquired | +6,905 | $3.79 | +$26,169.95 | 346,297 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −6,905 | $18.78 | −$129,675.9 | 339,392 | Direct | |
| Mar 20, 2026 | Common Stock | MOption exerciseAcquired | +1,596 | $3.79 | +$6,048.84 | 340,988 | Direct | |
| Mar 20, 2026 | Common Stock | SSaleDisposed | −1,596 | $18.95 | −$30,244.2 | 339,392 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Common Stock | MOption exerciseDisposed | −6,499 | $0.00 | $0 | 184,608 | Direct | |
| Mar 19, 2026 | Common Stock | MOption exerciseDisposed | −6,905 | $0.00 | $0 | 177,703 | Direct | |
| Mar 20, 2026 | Common Stock | MOption exerciseDisposed | −1,596 | $0.00 | $0 | 176,107 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.